Ress Life Investments A/S
27.1.2026 10:49:58 CET | Globenewswire | Press release
Ress Life Investments A/S announces capital increase
Ress Life Investments A/S announces capital increase
Ress Life Investments A/S
Nybrogade 12,
1203 Copenhagen K
Denmark
CVR nr. 33593163
www.resslifeinvestments.com
To: Nasdaq Copenhagen
Date: 27 January 2026
Corporate Announcement 04/2026
Ress Life Investments A/S announces capital increase.
The Board of Directors in Ress Life Investments A/S has today resolved to utilise its authorisation in article 4.8 of the articles of association to increase the company's share capital with nominally EUR 86,000 by issuance of 172 new shares with a nominal value of EUR 500 each at a price of EUR 2,245.67 per share of EUR 500 without pre-emption rights for the company's existing shareholders.
After the capital increase, the registered share capital of the company is EUR 58,014,500 divided into 116,029 shares of EUR 500 nominal value each. Each share of nominal EUR 500 carries one vote at general meetings in Ress Life Investments A/S.
The new shares will be admitted for trading and official listing on NASDAQ Copenhagen A/S under the same ISIN code as the company's existing shares.
Updated articles of association of the company are attached.
Questions related to this announcement can be made to the company’s AIF-manager, Resscapital AB.
Contact person:
Johan Jonson
johan.jonson@resscapital.com
Tel + 46 70 612 02 14
Attachments
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Meltwater27.1.2026 14:00:00 CET | Press release
Gwyneth Paltrow to Keynote Meltwater Summit 2026
Circle Cardiovascular Imaging Inc.27.1.2026 14:00:00 CET | Press release
Circle Cardiovascular Delivers a Unified Cardiac Imaging Platform
Fauna Robotics27.1.2026 14:00:00 CET | Press release
Fauna Robotics Unveils Sprout: A Lightweight, Interactive, and Capable Developer-Ready Humanoid Platform
eQ Oyj27.1.2026 14:00:00 CET | Press release
Shareholders’ Nomination Committee’s Proposals to Annual General Meeting 2026 concerning the Number of the Board Members, Their Remuneration and Reimbursement of Their Costs, and Nomination of the Board Members
Teva Pharmaceutical Industries Ltd27.1.2026 14:00:00 CET | Press release
Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom